Market Tracker

02/21 9:13am ET

Mylan NV (NASDAQ:MYL)

42.05
Delayed Data
As of Feb 17
 +0.05 / +0.12%
Today’s Change
33.60
Today|||52-Week Range
50.40
+10.22%
Year-to-Date

Today’s Trading

Previous close42.00
Today’s open41.86
Day’s range41.78 - 42.33
Volume6,616,387
Average volume (3 months)5,899,343
Market cap$22.5B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+10.09%
Earnings growth (next 5 years)+7.25%
Revenue growth (last year)+21.91%
P/E ratio18.1
Price/Sales2.84
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+0.31+0.26%
VRTXVertex Pharmaceutica...+0.63+0.72%
ZTSZoetis Inc-0.27-0.51%
BAXBaxter International...+0.31+0.63%
Data as of 4:01pm ET, 02/17/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$1.42
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts